This company manufactures raw materials for rapid diagnostic tests and dietary supplements. They offer self-monitoring kits for lifestyle diseases, including a predictive self-diagnostic kit for heart attack, making healthcare monitoring accessible and affordable.
Funding
Funding not disclosed
Founders
Product
Problem
Monitoring specific health conditions often requires frequent and costly visits to diagnostic centers. Traditional methods can be inconvenient and time-consuming, hindering proactive health management and early detection of potential issues.
Solution
BM Diagnostics offers a range of rapid diagnostic and self-monitoring kits designed for convenient and accessible health assessments. Their product line includes lateral flow tests for qualitative analysis and immunofluorescence assays for quantitative results, covering various health areas such as women's health, infectious diseases, and drug screening. The company's HeartBeat Test is a predictive self-diagnostic kit for heart attack risk, enabling individuals to monitor cardiac markers from home. BM Diagnostics aims to empower individuals and healthcare providers with accessible tools for proactive health management and timely intervention.
Target Audience
The primary target audience includes individuals seeking convenient self-monitoring tools, pharmacies, parapharmacies, and diagnostic centers looking to expand their testing capabilities.
Features
- Lateral flow tests for rapid qualitative analysis
- Immunofluorescence assays for quantitative detection of multiple markers
- Self-monitoring kits for women's health, infectious diseases and drug screening
- HeartBeat Test: a predictive self-diagnostic kit for heart attack risk
- Rapid diagnostic tests for H. pylori, Strep A, and UTIs
- Rapid drug tests for ABP, Alcohol, CAT, Amphetamine, CLO, Ketamine, MDMA, and MEP
- Other rapid diagnostic tests for Ferritin, sperm concentration, fecal occult blood, TSH, male fertility (SP-10), and Vitamin D